CNS Pharmaceuticals Inc. (CNSP)

AI Score

Unlock

1.09

0.05 (4.81%)

At close: Apr 25, 2025, 3:59 PM

1.06

-2.64%

After-hours: Apr 25, 2025, 05:47 PM EDT

CNS Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q2 2018	Q1 2018
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Jun 30, 2018	Mar 31, 2018
Cash & Equivalents	6.46M	6.97M	1.49M	815.23K	548.72K	909.55K	4.28M	5.11M	10.06M	7.03M	8.96M	12.44M	5M	8.33M	6.89M	11.08M	14.04M	1.31M	2.63M	5.38M	7.24M	630.11K	911.93K	155.02K	282.74K	380.69K	242.69K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	36.43K	18.37K	320.32K	55.3K	307.61K	262.73K	377.2K	438.13K	482.81K	929.04K	1.04M	1.13M	1.26M	334.14K	334.14K	334.14K	334.14K	440.9K	n/a	n/a	n/a	n/a	31K	108.22K	95.2K	96K	n/a
Receivables	882.54K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.7M	132.65K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.31M	414.97K	653.84K	786.05K	1.04M	1.15M	1.79M	1.86M	2.51M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	303.9K	269.4K	269.4K	272.4K	436.68K	6.45K
Total Current Assets	8.66M	7.39M	2.15M	1.6M	1.39M	2.06M	6.07M	6.97M	12.56M	8.7M	11.4M	14.73M	7.48M	11.16M	13.88M	12.79M	15.5M	2.52M	3.95M	6.19M	7.89M	1.39M	1.6M	444.42K	588.13K	819.03K	249.13K
Property-Plant & Equipment	6K	2.8K	3.55K	4.3K	4.93K	3.47K	3.38K	4.38K	5.66K	8.52K	10.97K	12.73K	16.11K	17.53K	20.89K	24.11K	23.43K	28.16K	31.32K	22.66K	18.16K	7.51K	8.21K	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	42.44K	21.18K	323.87K	59.6K	312.54K	266.2K	380.58K	442.52K	488.47K	937.56K	1.05M	1.14M	1.28M	351.66K	355.03K	358.24K	357.57K	469.06K	31.32K	22.66K	18.16K	7.51K	39.21K	108.22K	95.2K	96K	n/a
Total Assets	8.7M	7.41M	2.47M	1.66M	1.7M	2.33M	6.45M	7.41M	13.05M	9.64M	12.45M	15.87M	8.76M	11.51M	14.24M	13.14M	15.85M	2.99M	3.99M	6.21M	7.91M	1.4M	1.64M	552.64K	683.33K	915.03K	249.13K
Account Payables	n/a	n/a	6.64M	5.88M	5.83M	4.03M	3.57M	2.78M	3.68M	1.01M	490.89K	489.72K	1.52M	1.46M	892.49K	1.06M	946.33K	250.18K	150.51K	141.25K	289.5K	278.34K	164.96K	187.04K	128.87K	69.29K	79.84K
Deferred Revenue	n/a	n/a	n/a	-5.88M	n/a	-4.03M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	46.07K	35.99K	n/a	23.6K	n/a	n/a
Short-Term Debt	326.07K	31.19K	123.25K	213.1K	300.81K	41.9K	166.4K	289.07K	409.97K	39.26K	156.4K	272.57K	387.79K	44.63K	177.58K	309.13K	439.29K	n/a	n/a	n/a	n/a	300K	300K	290.83K	316.92K	374.04K	121.83K
Other Current Liabilities	2.2M	4.03M	n/a	n/a	n/a	n/a	n/a	n/a	828.39K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50K	n/a	763.25K	763.25K	763.25K	763.25K	641.13K	n/a
Total Current Liabilities	2.52M	4.06M	6.76M	6.09M	6.13M	4.07M	4M	3.92M	4.92M	1.24M	923.86K	1.07M	2.14M	2.41M	1.83M	1.9M	1.91M	510.78K	261.2K	336.04K	311K	1.4M	1.26M	1.27M	1.23M	1.1M	214.17K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.07M	4.09M	1.04M	n/a	762.29K	1.91M	1.51M	1.07M	1.37M	1.39M	250.18K	150.51K	191.25K	289.5K	588.34K	464.96K	n/a	445.78K	n/a	n/a
Total Liabilities	2.52M	4.06M	6.76M	6.09M	6.13M	4.07M	4M	3.92M	4.92M	1.24M	923.86K	1.07M	2.14M	2.41M	1.83M	1.9M	1.91M	510.78K	261.2K	336.04K	311K	1.4M	1.26M	1.27M	1.23M	1.1M	214.17K
Total Debt	326.07K	31.19K	123.25K	213.1K	300.81K	41.9K	166.4K	289.07K	409.97K	39.26K	156.4K	272.57K	387.79K	44.63K	177.58K	309.13K	439.29K	n/a	n/a	n/a	n/a	300K	300K	290.83K	316.92K	374.04K	121.83K
Common Stock	1.41K	33.45K	1.44K	10.67K	6.21K	4.21K	4.14K	2.23K	1.62K	40.03K	40.03K	40.03K	27.93K	27.46K	27.38K	25.35K	23.86K	16.65K	16.45K	16.45K	16.45K	13.59K	13.54K	12.7K	12.7K	10.54K	10.54K
Retained Earnings	-84.42M	-81.25M	-75.64M	-73.11M	-69.57M	-64.19M	-59.67M	-55.65M	-50.72M	-44.75M	-41.33M	-37.77M	-34.98M	-32.19M	-28.37M	-24.56M	-20.95M	-17.94M	-15.93M	-13.46M	-11.49M	-8.96M	-8.25M	-7.82M	-7.61M	-786.54K	-529.06K
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	n/a	n/a	-0.00	-0.00	n/a	n/a	n/a	n/a	0.00	n/a
Shareholders Equity	6.18M	3.35M	-4.29M	-4.43M	-4.43M	-1.74M	2.45M	3.49M	8.13M	8.39M	11.52M	14.8M	6.62M	9.1M	12.41M	11.24M	13.95M	2.47M	3.72M	5.88M	7.6M	216.00	377.7K	-716.78K	-549.3K	-184.14K	34.97K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a